Expression profiling suggests microglial impairment in human immunodeficiency virus neuropathogenesis

Objective CD16+/CD163+ macrophages (MΦs) and microglia accumulate in the brains of patients with human immunodeficiency virus (HIV) encephalitis (HIVE), a neuropathological correlate of the most severe form of HIV‐associated neurocognitive disorders, HIV‐associated dementia. Recently, we found that...

Full description

Saved in:
Bibliographic Details
Published inAnnals of neurology Vol. 83; no. 2; pp. 406 - 417
Main Authors Ginsberg, Stephen D., Alldred, Melissa J., Gunnam, Satya M., Schiroli, Consuelo, Lee, Sang Han, Morgello, Susan, Fischer, Tracy
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.02.2018
Subjects
Online AccessGet full text
ISSN0364-5134
1531-8249
1531-8249
DOI10.1002/ana.25160

Cover

Loading…
Abstract Objective CD16+/CD163+ macrophages (MΦs) and microglia accumulate in the brains of patients with human immunodeficiency virus (HIV) encephalitis (HIVE), a neuropathological correlate of the most severe form of HIV‐associated neurocognitive disorders, HIV‐associated dementia. Recently, we found that some parenchymal microglia in brain of HIV+ subjects without encephalitis (HIV/noE) but with varying degrees of neurocognitive impairment express CD16 and CD163, even in the absence of detectable virus production. To further our understanding of microglial activation in HIV, we investigated expression of specific genes by profiling parenchymal microglia from archival brain tissue of patients with HIVE and HIV/noE, and HIV− controls. Methods Single‐population microarray analyses were performed on ∼2,500 laser capture microdissected CD163+, CD16+, or CD68+ MΦs/microglia per case, using terminal continuation RNA amplification and a custom‐designed array platform. Results Several classes of microglial transcripts in HIVE and HIV/noE were altered, relative to HIV− subjects, including factors related to cell stress, immune activation, and apoptosis. Additionally, several neurotrophic factors were reduced in HIV infection, suggesting an additional mechanism of neuropathogenesis. The majority of transcripts altered in HIVE displayed intermediate changes in HIV/noE. Interpretation Our results support the notion that microglia contribute to the maintenance of brain homeostasis and their potential loss of function in the context of chronic inflammation contributes to neuropathogenesis. Furthermore, they indicate the utility of profiling MΦs/microglia to increase our understanding of microglia function, as well as to ascertain alterations in specific pathways, genes, and potentially, encoded proteins that may be amenable to targeted treatment modalities in diseases affecting the brain. Ann Neurol 2018;83:406–417
AbstractList Objective CD16+/CD163+ macrophages (MΦs) and microglia accumulate in the brains of patients with human immunodeficiency virus (HIV) encephalitis (HIVE), a neuropathological correlate of the most severe form of HIV‐associated neurocognitive disorders, HIV‐associated dementia. Recently, we found that some parenchymal microglia in brain of HIV+ subjects without encephalitis (HIV/noE) but with varying degrees of neurocognitive impairment express CD16 and CD163, even in the absence of detectable virus production. To further our understanding of microglial activation in HIV, we investigated expression of specific genes by profiling parenchymal microglia from archival brain tissue of patients with HIVE and HIV/noE, and HIV− controls. Methods Single‐population microarray analyses were performed on ∼2,500 laser capture microdissected CD163+, CD16+, or CD68+ MΦs/microglia per case, using terminal continuation RNA amplification and a custom‐designed array platform. Results Several classes of microglial transcripts in HIVE and HIV/noE were altered, relative to HIV− subjects, including factors related to cell stress, immune activation, and apoptosis. Additionally, several neurotrophic factors were reduced in HIV infection, suggesting an additional mechanism of neuropathogenesis. The majority of transcripts altered in HIVE displayed intermediate changes in HIV/noE. Interpretation Our results support the notion that microglia contribute to the maintenance of brain homeostasis and their potential loss of function in the context of chronic inflammation contributes to neuropathogenesis. Furthermore, they indicate the utility of profiling MΦs/microglia to increase our understanding of microglia function, as well as to ascertain alterations in specific pathways, genes, and potentially, encoded proteins that may be amenable to targeted treatment modalities in diseases affecting the brain. Ann Neurol 2018;83:406–417
CD16 /CD163 macrophages (MΦs) and microglia accumulate in the brains of patients with human immunodeficiency virus (HIV) encephalitis (HIVE), a neuropathological correlate of the most severe form of HIV-associated neurocognitive disorders, HIV-associated dementia. Recently, we found that some parenchymal microglia in brain of HIV subjects without encephalitis (HIV/noE) but with varying degrees of neurocognitive impairment express CD16 and CD163, even in the absence of detectable virus production. To further our understanding of microglial activation in HIV, we investigated expression of specific genes by profiling parenchymal microglia from archival brain tissue of patients with HIVE and HIV/noE, and HIV controls. Single-population microarray analyses were performed on ∼2,500 laser capture microdissected CD163 , CD16 , or CD68 MΦs/microglia per case, using terminal continuation RNA amplification and a custom-designed array platform. Several classes of microglial transcripts in HIVE and HIV/noE were altered, relative to HIV subjects, including factors related to cell stress, immune activation, and apoptosis. Additionally, several neurotrophic factors were reduced in HIV infection, suggesting an additional mechanism of neuropathogenesis. The majority of transcripts altered in HIVE displayed intermediate changes in HIV/noE. Our results support the notion that microglia contribute to the maintenance of brain homeostasis and their potential loss of function in the context of chronic inflammation contributes to neuropathogenesis. Furthermore, they indicate the utility of profiling MΦs/microglia to increase our understanding of microglia function, as well as to ascertain alterations in specific pathways, genes, and potentially, encoded proteins that may be amenable to targeted treatment modalities in diseases affecting the brain. Ann Neurol 2018;83:406-417.
CD16+ /CD163+ macrophages (MΦs) and microglia accumulate in the brains of patients with human immunodeficiency virus (HIV) encephalitis (HIVE), a neuropathological correlate of the most severe form of HIV-associated neurocognitive disorders, HIV-associated dementia. Recently, we found that some parenchymal microglia in brain of HIV+ subjects without encephalitis (HIV/noE) but with varying degrees of neurocognitive impairment express CD16 and CD163, even in the absence of detectable virus production. To further our understanding of microglial activation in HIV, we investigated expression of specific genes by profiling parenchymal microglia from archival brain tissue of patients with HIVE and HIV/noE, and HIV- controls.OBJECTIVECD16+ /CD163+ macrophages (MΦs) and microglia accumulate in the brains of patients with human immunodeficiency virus (HIV) encephalitis (HIVE), a neuropathological correlate of the most severe form of HIV-associated neurocognitive disorders, HIV-associated dementia. Recently, we found that some parenchymal microglia in brain of HIV+ subjects without encephalitis (HIV/noE) but with varying degrees of neurocognitive impairment express CD16 and CD163, even in the absence of detectable virus production. To further our understanding of microglial activation in HIV, we investigated expression of specific genes by profiling parenchymal microglia from archival brain tissue of patients with HIVE and HIV/noE, and HIV- controls.Single-population microarray analyses were performed on ∼2,500 laser capture microdissected CD163+ , CD16+ , or CD68+ MΦs/microglia per case, using terminal continuation RNA amplification and a custom-designed array platform.METHODSSingle-population microarray analyses were performed on ∼2,500 laser capture microdissected CD163+ , CD16+ , or CD68+ MΦs/microglia per case, using terminal continuation RNA amplification and a custom-designed array platform.Several classes of microglial transcripts in HIVE and HIV/noE were altered, relative to HIV- subjects, including factors related to cell stress, immune activation, and apoptosis. Additionally, several neurotrophic factors were reduced in HIV infection, suggesting an additional mechanism of neuropathogenesis. The majority of transcripts altered in HIVE displayed intermediate changes in HIV/noE.RESULTSSeveral classes of microglial transcripts in HIVE and HIV/noE were altered, relative to HIV- subjects, including factors related to cell stress, immune activation, and apoptosis. Additionally, several neurotrophic factors were reduced in HIV infection, suggesting an additional mechanism of neuropathogenesis. The majority of transcripts altered in HIVE displayed intermediate changes in HIV/noE.Our results support the notion that microglia contribute to the maintenance of brain homeostasis and their potential loss of function in the context of chronic inflammation contributes to neuropathogenesis. Furthermore, they indicate the utility of profiling MΦs/microglia to increase our understanding of microglia function, as well as to ascertain alterations in specific pathways, genes, and potentially, encoded proteins that may be amenable to targeted treatment modalities in diseases affecting the brain. Ann Neurol 2018;83:406-417.INTERPRETATIONOur results support the notion that microglia contribute to the maintenance of brain homeostasis and their potential loss of function in the context of chronic inflammation contributes to neuropathogenesis. Furthermore, they indicate the utility of profiling MΦs/microglia to increase our understanding of microglia function, as well as to ascertain alterations in specific pathways, genes, and potentially, encoded proteins that may be amenable to targeted treatment modalities in diseases affecting the brain. Ann Neurol 2018;83:406-417.
ObjectiveCD16+/CD163+ macrophages (MΦs) and microglia accumulate in the brains of patients with human immunodeficiency virus (HIV) encephalitis (HIVE), a neuropathological correlate of the most severe form of HIV‐associated neurocognitive disorders, HIV‐associated dementia. Recently, we found that some parenchymal microglia in brain of HIV+ subjects without encephalitis (HIV/noE) but with varying degrees of neurocognitive impairment express CD16 and CD163, even in the absence of detectable virus production. To further our understanding of microglial activation in HIV, we investigated expression of specific genes by profiling parenchymal microglia from archival brain tissue of patients with HIVE and HIV/noE, and HIV− controls.MethodsSingle‐population microarray analyses were performed on ∼2,500 laser capture microdissected CD163+, CD16+, or CD68+ MΦs/microglia per case, using terminal continuation RNA amplification and a custom‐designed array platform.ResultsSeveral classes of microglial transcripts in HIVE and HIV/noE were altered, relative to HIV− subjects, including factors related to cell stress, immune activation, and apoptosis. Additionally, several neurotrophic factors were reduced in HIV infection, suggesting an additional mechanism of neuropathogenesis. The majority of transcripts altered in HIVE displayed intermediate changes in HIV/noE.InterpretationOur results support the notion that microglia contribute to the maintenance of brain homeostasis and their potential loss of function in the context of chronic inflammation contributes to neuropathogenesis. Furthermore, they indicate the utility of profiling MΦs/microglia to increase our understanding of microglia function, as well as to ascertain alterations in specific pathways, genes, and potentially, encoded proteins that may be amenable to targeted treatment modalities in diseases affecting the brain. Ann Neurol 2018;83:406–417
Author Morgello, Susan
Alldred, Melissa J.
Schiroli, Consuelo
Ginsberg, Stephen D.
Gunnam, Satya M.
Fischer, Tracy
Lee, Sang Han
Author_xml – sequence: 1
  givenname: Stephen D.
  orcidid: 0000-0002-1797-4288
  surname: Ginsberg
  fullname: Ginsberg, Stephen D.
  organization: New York University Langone Medical Center
– sequence: 2
  givenname: Melissa J.
  surname: Alldred
  fullname: Alldred, Melissa J.
  organization: New York University Langone Medical Center
– sequence: 3
  givenname: Satya M.
  surname: Gunnam
  fullname: Gunnam, Satya M.
  organization: Temple University School of Medicine
– sequence: 4
  givenname: Consuelo
  surname: Schiroli
  fullname: Schiroli, Consuelo
  organization: Temple University School of Medicine
– sequence: 5
  givenname: Sang Han
  surname: Lee
  fullname: Lee, Sang Han
  organization: Nathan Kline Institute
– sequence: 6
  givenname: Susan
  surname: Morgello
  fullname: Morgello, Susan
  organization: Icahn School of Medicine at Mount Sinai
– sequence: 7
  givenname: Tracy
  orcidid: 0000-0003-4859-3776
  surname: Fischer
  fullname: Fischer, Tracy
  email: tlfsmith@temple.edu
  organization: Temple University School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29369399$$D View this record in MEDLINE/PubMed
BookMark eNp9kU9P3DAQxa0KVBbooV8AReLSHgL-s3bs4wrRFgnBhbvlOE4YlNjBjqH77et2oQckOI00-r2nmfcO0Z4P3iH0leAzgjE9N96cUU4E_oRWhDNSS7pWe2iFmVjXnLD1ATpM6QFjrATBn9EBVUwoptQKucvfc3QpQfDVHEMPI_ihSnkYXFpSNYGNYRjBjBVMs4E4Ob9U4Kv7PBlfdlP2oXM9WHDebqsniDlV3uUYZrPch8F5lyAdo_3ejMl9eZlH6O7H5d3Fr_r69ufVxea6tkxKXFvZ8a7vJFv3rFeWC2541xrcCmk4b3mDW2cVlh1pulZRTg1vpSW0aWlDjGVH6NvOtnzymMsDeoJk3Tga70JOmihFiBSCi4KevkEfQo6-HKcpxkJQ1lBSqJMXKreT6_QcYTJxq1_zK8D3HVBiSim6_j9CsP7bjS7d6H_dFPb8DWthMUtJfokGxo8UzzC67fvWenOz2Sn-AISWoYE
CitedBy_id crossref_primary_10_1016_j_bbih_2021_100235
crossref_primary_10_1002_glia_23634
crossref_primary_10_1097_WCO_0000000000000807
crossref_primary_10_1016_j_heliyon_2023_e21307
crossref_primary_10_1016_j_neurot_2024_e00373
crossref_primary_10_1371_journal_ppat_1011290
crossref_primary_10_3390_ijms222212457
crossref_primary_10_26508_lsa_202402879
crossref_primary_10_3389_fimmu_2021_804625
crossref_primary_10_3390_microorganisms10112244
crossref_primary_10_1111_febs_16031
crossref_primary_10_1038_s41582_023_00879_y
crossref_primary_10_1001_jamaoto_2020_2366
crossref_primary_10_1007_s12640_019_00077_z
crossref_primary_10_1186_s12981_023_00511_5
crossref_primary_10_1186_s12974_019_1565_6
crossref_primary_10_1002_dneu_22700
crossref_primary_10_1007_s13365_019_00735_0
crossref_primary_10_1096_fj_201802669RR
crossref_primary_10_1002_glia_23726
crossref_primary_10_3390_cells12131767
crossref_primary_10_1007_s13365_019_00737_y
crossref_primary_10_1007_s13365_020_00842_3
crossref_primary_10_3390_cells13171415
crossref_primary_10_1186_s12974_019_1443_2
crossref_primary_10_3389_fcimb_2019_00362
crossref_primary_10_1038_s41419_019_1920_7
crossref_primary_10_1016_j_stemcr_2020_02_010
crossref_primary_10_2139_ssrn_4142784
crossref_primary_10_3390_vaccines9070710
crossref_primary_10_3390_v16050693
crossref_primary_10_1097_QAD_0000000000002893
crossref_primary_10_1016_j_celrep_2023_112110
crossref_primary_10_1128_MMBR_00080_19
crossref_primary_10_1128_spectrum_04315_22
crossref_primary_10_3390_biomedicines9080925
Cites_doi 10.1016/S0165-5728(00)00463-X
10.1038/mp.2009.52
10.1002/ana.410310402
10.1212/WNL.47.5.1247
10.1016/j.autrev.2016.07.022
10.3390/ijms9112091
10.1038/2677
10.1001/archneur.64.12.1771
10.3389/fncel.2017.00216
10.1007/978-1-59745-188-8_10
10.1177/0962280207081240
10.3233/JAD-141116
10.1002/cne.23663
10.1161/01.RES.0000187467.67684.43
10.1097/NEN.0b013e31819715df
10.1111/j.1471-4159.2006.03764.x
10.1371/journal.pone.0155307
10.1074/jbc.M112.410720
10.1016/j.nbd.2011.10.022
10.1016/j.jneuroim.2017.02.017
10.1007/s13365-014-0270-6
10.1016/j.nurx.2006.05.007
10.1038/sj.thj.6200252
10.1198/016214506000001211
10.1080/135502801753248114
10.1016/S0002-9440(10)63767-4
10.1046/j.1471-4159.1999.0722272.x
10.1126/science.8346443
10.1038/labinvest.3700005
10.1016/j.jpsychires.2006.10.013
10.1097/00001756-199407000-00026
10.1007/s13365-014-0239-5
10.1016/j.cell.2009.08.037
10.3389/fneur.2017.00351
10.1186/s12974-015-0272-1
10.1073/pnas.0502878102
10.1016/j.biopsych.2010.05.030
10.1212/WNL.41.6.778
10.1016/j.ymeth.2005.09.003
10.3233/JAD-2009-1196
10.2174/1570162X12666140526114956
10.1159/000113710
10.1212/WNL.0000000000002485
10.1038/356768a0
10.1111/j.2517-6161.1995.tb02031.x
10.1007/s13365-016-0505-9
10.1016/j.jneumeth.2008.10.027
10.1212/WNL.56.2.194
10.1002/ana.410340112
ContentType Journal Article
Copyright 2018 American Neurological Association
2018 American Neurological Association.
Copyright_xml – notice: 2018 American Neurological Association
– notice: 2018 American Neurological Association.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7U7
C1K
K9.
7X8
DOI 10.1002/ana.25160
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Toxicology Abstracts
Neurosciences Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1531-8249
EndPage 417
ExternalDocumentID 29369399
10_1002_ana_25160
ANA25160
Genre article
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: National Institute of Mental Health
  funderid: P01MH105303 ; U24MH100931
– fundername: NIH
  funderid: R01 NS063605 ; P01 MH105303 ; R01 AG043375 ; P01 AG014449 ; P01 AG017617 ; U24 MH100931
– fundername: National Institute of Neurological Disorders and Stroke
  funderid: R01NS063605
– fundername: National Institute on Aging
  funderid: P01AG014449 ; R01AG043375
– fundername: NIMH NIH HHS
  grantid: U24 MH100931
– fundername: NINDS NIH HHS
  grantid: R01 NS063605
– fundername: NIA NIH HHS
  grantid: P01 AG014449
– fundername: NIA NIH HHS
  grantid: R01 AG043375
– fundername: NIA NIH HHS
  grantid: P01 AG017617
– fundername: NIMH NIH HHS
  grantid: P01 MH105303
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1CY
1L6
1OB
1OC
1ZS
23M
2QL
31~
33P
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
6J9
6P2
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAEJM
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AAQQT
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABIVO
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBMB
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACRZS
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFAZI
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AI.
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
AJJEV
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRMAN
DRSTM
EBS
EJD
EMOBN
F00
F01
F04
F5P
F8P
FEDTE
FUBAC
FYBCS
G-S
G.N
GNP
GODZA
GOZPB
GRPMH
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
J5H
JPC
KBYEO
KD1
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LXL
LXN
LXY
LYRES
M6M
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N4W
N9A
NF~
NNB
O66
O9-
OHT
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.-
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWD
RWI
RX1
SAMSI
SJN
SUPJJ
TEORI
UB1
V2E
V8K
V9Y
VH1
W8V
W99
WBKPD
WH7
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
XJT
XPP
XSW
XV2
YOC
YQJ
ZGI
ZRF
ZRR
ZXP
ZZTAW
~IA
~WT
~X8
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7TK
7U7
C1K
K9.
7X8
ID FETCH-LOGICAL-c3880-c8d5dfd834f3f9c565a5dba0b68a55b570bec908d17db9252a5b8c127b271ac3
IEDL.DBID DR2
ISSN 0364-5134
1531-8249
IngestDate Fri Jul 11 10:39:31 EDT 2025
Fri Jul 25 12:23:28 EDT 2025
Mon Jul 21 05:41:58 EDT 2025
Thu Apr 24 23:02:23 EDT 2025
Tue Jul 01 02:24:09 EDT 2025
Wed Jan 22 17:12:13 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
2018 American Neurological Association.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3880-c8d5dfd834f3f9c565a5dba0b68a55b570bec908d17db9252a5b8c127b271ac3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-1797-4288
0000-0003-4859-3776
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/5822676
PMID 29369399
PQID 2006623721
PQPubID 946345
PageCount 12
ParticipantIDs proquest_miscellaneous_1991186656
proquest_journals_2006623721
pubmed_primary_29369399
crossref_primary_10_1002_ana_25160
crossref_citationtrail_10_1002_ana_25160
wiley_primary_10_1002_ana_25160_ANA25160
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate February 2018
2018-02-00
20180201
PublicationDateYYYYMMDD 2018-02-01
PublicationDate_xml – month: 02
  year: 2018
  text: February 2018
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Minneapolis
PublicationTitle Annals of neurology
PublicationTitleAlternate Ann Neurol
PublicationYear 2018
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2004; 164
2007; 102
2017; 8
2008; 9
2013; 288
2008; 5
2014; 20
2009; 14
1993; 34
2010; 68
2005; 102
1991; 41
1992; 356
2015; 43
2008; 439
2016; 86
2003; 4
2005; 37
2007; 64
2001; 56
2014; 12
2009; 18
2015; 12
2009; 68
2004; 84
2006; 97
2015; 523
1995; 57
2008; 17
2017; 23
2009; 177
1993; 261
2006; 3
1992; 31
2016; 15
2016; 11
2009; 139
2017; 306
2001; 7
2017; 11
2015; 21
2005; 97
2008; 42
1999; 72
1996; 47
2012; 45
1998; 4
1994; 5
2001; 115
e_1_2_8_28_1
e_1_2_8_24_1
e_1_2_8_47_1
e_1_2_8_26_1
e_1_2_8_49_1
e_1_2_8_3_1
e_1_2_8_5_1
e_1_2_8_7_1
e_1_2_8_9_1
e_1_2_8_20_1
e_1_2_8_43_1
e_1_2_8_22_1
e_1_2_8_45_1
e_1_2_8_41_1
e_1_2_8_17_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_15_1
e_1_2_8_38_1
e_1_2_8_32_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_30_1
e_1_2_8_29_1
e_1_2_8_25_1
e_1_2_8_46_1
e_1_2_8_27_1
e_1_2_8_48_1
e_1_2_8_2_1
e_1_2_8_4_1
e_1_2_8_6_1
e_1_2_8_8_1
e_1_2_8_21_1
e_1_2_8_42_1
e_1_2_8_23_1
e_1_2_8_44_1
e_1_2_8_40_1
e_1_2_8_18_1
e_1_2_8_39_1
e_1_2_8_14_1
e_1_2_8_35_1
e_1_2_8_16_1
e_1_2_8_37_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_50_1
References_xml – volume: 57
  start-page: 289
  year: 1995
  end-page: 300
  article-title: Controlling the false discovery rate: a practical and powerful approach to multiple testing
  publication-title: J R Stat Soc Series B Stat Methodol
– volume: 64
  start-page: 1771
  year: 2007
  end-page: 1776
  article-title: Alpha7 nicotinic receptor up‐regulation in cholinergic basal forebrain neurons in Alzheimer disease
  publication-title: Arch Neurol
– volume: 8
  start-page: 351
  year: 2017
  article-title: Monitoring the neuroinflammatory response following acute brain injury
  publication-title: Front Neurol
– volume: 11
  start-page: e0155307
  year: 2016
  article-title: The effect of a high‐fat diet on brain plasticity, inflammation and cognition in female ApoE4‐knockin and ApoE‐knockout mice
  publication-title: PLoS One
– volume: 11
  start-page: 216
  year: 2017
  article-title: Brain and peripheral atypical inflammatory mediators potentiate neuroinflammation and neurodegeneration
  publication-title: Front Cell Neurosci
– volume: 4
  start-page: 277
  year: 2003
  end-page: 284
  article-title: Lineage‐dependent NF‐kappaB activation contributes to the resistance of human macrophages to apoptosis
  publication-title: Hematol J
– volume: 42
  start-page: 151
  year: 2008
  end-page: 157
  article-title: Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide
  publication-title: J Psychiatr Res
– volume: 288
  start-page: 20745
  year: 2013
  end-page: 20757
  article-title: Accelerated development of pulmonary fibrosis via Cu,Zn‐superoxide dismutase‐induced alternative activation of macrophages
  publication-title: J Biol Chem
– volume: 7
  start-page: 528
  year: 2001
  end-page: 541
  article-title: CNS invasion by CD14+/CD16+ peripheral blood‐derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection
  publication-title: J Neurovirol
– volume: 18
  start-page: 885
  year: 2009
  end-page: 896
  article-title: Galanin fiber hyperinnervation preserves neuroprotective gene expression in cholinergic basal forebrain neurons in Alzheimer's disease
  publication-title: J Alzheimers Dis
– volume: 139
  start-page: 610
  year: 2009
  end-page: 622
  article-title: Profiling the human protein‐DNA interactome reveals MAPK1 as a transcriptional repressor of interferon signalling
  publication-title: Cell
– volume: 97
  start-page: 922
  year: 2005
  end-page: 927
  article-title: Apolipoprotein E suppresses the type I inflammatory response in vivo
  publication-title: Circ Res
– volume: 45
  start-page: 751
  year: 2012
  end-page: 762
  article-title: Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction
  publication-title: Neurobiol Dis
– volume: 47
  start-page: 1247
  year: 1996
  end-page: 1253
  article-title: Clinical confirmation of the American Academy of Neurology algorithm for HIV‐1‐associated cognitive/motor disorder
  publication-title: Neurology
– volume: 43
  start-page: 1199
  year: 2015
  end-page: 1213
  article-title: A global immune deficit in Alzheimer's disease and mild cognitive impairment disclosed by a novel data mining process
  publication-title: J Alzheimers Dis
– volume: 20
  start-page: 219
  year: 2014
  end-page: 232
  article-title: Regional brain distribution of translocator protein using [(11)C]DPA‐713 PET in individuals infected with HIV
  publication-title: J Neurovirol
– volume: 5
  start-page: 228
  year: 2008
  end-page: 231
  article-title: Galanin hyperinnervation upregulates choline acetyltransferase expression in cholinergic basal forebrain neurons in Alzheimer's disease
  publication-title: Neurodegener Dis
– volume: 115
  start-page: 182
  year: 2001
  end-page: 191
  article-title: Expression of inducible nitric oxide synthase, interleukin‐1 and caspase‐1 in HIV‐1 encephalitis
  publication-title: J Neuroimmunol
– volume: 34
  start-page: 65
  year: 1993
  end-page: 70
  article-title: Diffuse microgliosis associated with cerebral atrophy in the acquired immunodeficiency syndrome
  publication-title: Ann Neurol
– volume: 9
  start-page: 2091
  year: 2008
  end-page: 2104
  article-title: Terminal continuation (TC) RNA amplification enables expression profiling using minute RNA input obtained from mouse brain
  publication-title: Int J Mol Sci
– volume: 102
  start-page: 93
  year: 2007
  end-page: 103
  article-title: Correlation and large‐scale simultaneous significance testing
  publication-title: J Am Stat Assoc
– volume: 102
  start-page: 13915
  year: 2005
  end-page: 13920
  article-title: Antioxidants modulate mitochondrial PKA and increase CREB binding to D‐loop DNA of the mitochondrial genome in neurons
  publication-title: Proc Natl Acad Sci U S A
– volume: 68
  start-page: 199
  year: 2009
  end-page: 209
  article-title: Reduced expression of excitatory amino acid transporter 2 and diffuse microglial activation in the cerebral cortex in AIDS cases with or without HIV encephalitis
  publication-title: J Neuropathol Exp Neurol
– volume: 97
  start-page: 475
  year: 2006
  end-page: 487
  article-title: Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease
  publication-title: J Neurochem
– volume: 523
  start-page: 61
  year: 2015
  end-page: 74
  article-title: Expression profile analysis of vulnerable CA1 pyramidal neurons in young‐middle‐aged Ts65Dn mice
  publication-title: J Comp Neurol
– volume: 23
  start-page: 369
  year: 2017
  end-page: 375
  article-title: Cerebrospinal fluid biomarkers and HIV‐associated neurocognitive disorders in HIV‐infected individuals in Rakai, Uganda
  publication-title: J Neurovirol
– volume: 439
  start-page: 147
  year: 2008
  end-page: 158
  article-title: Transcriptional profiling of small samples in the central nervous system
  publication-title: Methods Mol Biol
– volume: 306
  start-page: 40
  year: 2017
  end-page: 45
  article-title: Untreated relapsing remitting multiple sclerosis patients show antibody production against latent Epstein Barr virus (EBV) antigens mainly in the periphery and innate immune IL‐8 responses preferentially in the CNS
  publication-title: J Neuroimmunol
– volume: 12
  start-page: 97
  year: 2014
  end-page: 110
  article-title: Brain inflammation is a common feature of HIV‐infected patients without HIV encephalitis or productive brain infection
  publication-title: Curr HIV Res
– volume: 3
  start-page: 302
  year: 2006
  end-page: 318
  article-title: Single cell gene expression profiling in Alzheimer's disease
  publication-title: NeuroRx
– volume: 56
  start-page: 194
  year: 2001
  end-page: 200
  article-title: APOE genotype predicts AD and other dementia but not ischemic cerebrovascular disease
  publication-title: Neurology
– volume: 14
  start-page: 1069
  year: 2009
  end-page: 1071
  article-title: Activation of brain interleukin‐1beta in schizophrenia
  publication-title: Mol Psychiatry
– volume: 5
  start-page: 1514
  year: 1994
  end-page: 1516
  article-title: Activation of microglia in HIV‐1 infected brains is not dependent on the presence of HIV‐1 antigens
  publication-title: Neuroreport
– volume: 177
  start-page: 381
  year: 2009
  end-page: 385
  article-title: Terminal continuation (TC) RNA amplification without second strand synthesis
  publication-title: J Neurosci Methods
– volume: 31
  start-page: 349
  year: 1992
  end-page: 360
  article-title: Cytokine expression in the brain during the acquired immunodeficiency syndrome
  publication-title: Ann Neurol
– volume: 164
  start-page: 2089
  year: 2004
  end-page: 2099
  article-title: Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy
  publication-title: Am J Pathol
– volume: 37
  start-page: 229
  year: 2005
  end-page: 237
  article-title: RNA amplification strategies for small sample populations
  publication-title: Methods
– volume: 12
  start-page: 58
  year: 2015
  article-title: Role for cFMS in maintaining alternative macrophage polarization in SIV infection: implications for HIV neuropathogenesis
  publication-title: J Neuroinflammation
– volume: 84
  start-page: 131
  year: 2004
  end-page: 137
  article-title: Amplification of transcripts using terminal continuation
  publication-title: Lab Invest
– volume: 261
  start-page: 921
  year: 1993
  end-page: 923
  article-title: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
  publication-title: Science
– volume: 17
  start-page: 53
  year: 2008
  end-page: 73
  article-title: Joint modelling of mixed outcome types using latent variables
  publication-title: Stat Methods Med Res
– volume: 86
  start-page: 1425
  year: 2016
  end-page: 1432
  article-title: Neuroinflammation in treated HIV‐positive individuals: a TSPO PET study
  publication-title: Neurology
– volume: 72
  start-page: 2272
  year: 1999
  end-page: 2277
  article-title: Cyclic AMP‐responsive element binding protein in brain mitochondria
  publication-title: J Neurochem
– volume: 68
  start-page: 885
  year: 2010
  end-page: 893
  article-title: Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression
  publication-title: Biol Psychiatry
– volume: 4
  start-page: 1182
  year: 1998
  end-page: 1184
  article-title: HIV‐infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy
  publication-title: Nat Med
– volume: 15
  start-page: 1005
  year: 2016
  end-page: 1011
  article-title: Parkinson's disease: autoimmunity and neuroinflammation
  publication-title: Autoimmun Rev
– volume: 21
  start-page: 249
  year: 2015
  end-page: 256
  article-title: Evidence for cFMS signaling in HIV production by brain macrophages and microglia
  publication-title: J Neurovirol
– volume: 356
  start-page: 768
  year: 1992
  end-page: 774
  article-title: A novel heterodimeric cysteine protease is required for interleukin‐1 beta processing in monocytes
  publication-title: Nature
– volume: 41
  start-page: 778
  year: 1991
  end-page: 785
  article-title: Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus‐type 1 (HIV‐1) infection. Report of a working group of the American Academy of Neurology AIDS Task Force
  publication-title: Neurology
– ident: e_1_2_8_49_1
  doi: 10.1016/S0165-5728(00)00463-X
– ident: e_1_2_8_11_1
  doi: 10.1038/mp.2009.52
– ident: e_1_2_8_50_1
  doi: 10.1002/ana.410310402
– ident: e_1_2_8_13_1
  doi: 10.1212/WNL.47.5.1247
– ident: e_1_2_8_9_1
  doi: 10.1016/j.autrev.2016.07.022
– ident: e_1_2_8_16_1
  doi: 10.3390/ijms9112091
– ident: e_1_2_8_39_1
  doi: 10.1038/2677
– ident: e_1_2_8_46_1
  doi: 10.1001/archneur.64.12.1771
– ident: e_1_2_8_7_1
  doi: 10.3389/fncel.2017.00216
– ident: e_1_2_8_22_1
  doi: 10.1007/978-1-59745-188-8_10
– ident: e_1_2_8_25_1
  doi: 10.1177/0962280207081240
– ident: e_1_2_8_8_1
  doi: 10.3233/JAD-141116
– ident: e_1_2_8_20_1
  doi: 10.1002/cne.23663
– ident: e_1_2_8_41_1
  doi: 10.1161/01.RES.0000187467.67684.43
– ident: e_1_2_8_6_1
  doi: 10.1097/NEN.0b013e31819715df
– ident: e_1_2_8_23_1
  doi: 10.1111/j.1471-4159.2006.03764.x
– ident: e_1_2_8_42_1
  doi: 10.1371/journal.pone.0155307
– ident: e_1_2_8_37_1
  doi: 10.1074/jbc.M112.410720
– ident: e_1_2_8_19_1
  doi: 10.1016/j.nbd.2011.10.022
– ident: e_1_2_8_29_1
  doi: 10.1016/j.jneuroim.2017.02.017
– ident: e_1_2_8_34_1
  doi: 10.1007/s13365-014-0270-6
– ident: e_1_2_8_24_1
  doi: 10.1016/j.nurx.2006.05.007
– ident: e_1_2_8_36_1
  doi: 10.1038/sj.thj.6200252
– ident: e_1_2_8_27_1
  doi: 10.1198/016214506000001211
– ident: e_1_2_8_2_1
  doi: 10.1080/135502801753248114
– ident: e_1_2_8_14_1
  doi: 10.1016/S0002-9440(10)63767-4
– ident: e_1_2_8_43_1
  doi: 10.1046/j.1471-4159.1999.0722272.x
– ident: e_1_2_8_38_1
  doi: 10.1126/science.8346443
– ident: e_1_2_8_15_1
  doi: 10.1038/labinvest.3700005
– ident: e_1_2_8_10_1
  doi: 10.1016/j.jpsychires.2006.10.013
– ident: e_1_2_8_5_1
  doi: 10.1097/00001756-199407000-00026
– ident: e_1_2_8_31_1
  doi: 10.1007/s13365-014-0239-5
– ident: e_1_2_8_45_1
  doi: 10.1016/j.cell.2009.08.037
– ident: e_1_2_8_30_1
  doi: 10.3389/fneur.2017.00351
– ident: e_1_2_8_35_1
  doi: 10.1186/s12974-015-0272-1
– ident: e_1_2_8_44_1
  doi: 10.1073/pnas.0502878102
– ident: e_1_2_8_18_1
  doi: 10.1016/j.biopsych.2010.05.030
– ident: e_1_2_8_12_1
  doi: 10.1212/WNL.41.6.778
– ident: e_1_2_8_21_1
  doi: 10.1016/j.ymeth.2005.09.003
– ident: e_1_2_8_48_1
  doi: 10.3233/JAD-2009-1196
– ident: e_1_2_8_3_1
  doi: 10.2174/1570162X12666140526114956
– ident: e_1_2_8_47_1
  doi: 10.1159/000113710
– ident: e_1_2_8_32_1
  doi: 10.1212/WNL.0000000000002485
– ident: e_1_2_8_33_1
  doi: 10.1038/356768a0
– ident: e_1_2_8_26_1
  doi: 10.1111/j.2517-6161.1995.tb02031.x
– ident: e_1_2_8_28_1
  doi: 10.1007/s13365-016-0505-9
– ident: e_1_2_8_17_1
  doi: 10.1016/j.jneumeth.2008.10.027
– ident: e_1_2_8_40_1
  doi: 10.1212/WNL.56.2.194
– ident: e_1_2_8_4_1
  doi: 10.1002/ana.410340112
SSID ssj0009610
Score 2.4272552
Snippet Objective CD16+/CD163+ macrophages (MΦs) and microglia accumulate in the brains of patients with human immunodeficiency virus (HIV) encephalitis (HIVE), a...
CD16 /CD163 macrophages (MΦs) and microglia accumulate in the brains of patients with human immunodeficiency virus (HIV) encephalitis (HIVE), a...
ObjectiveCD16+/CD163+ macrophages (MΦs) and microglia accumulate in the brains of patients with human immunodeficiency virus (HIV) encephalitis (HIVE), a...
CD16+ /CD163+ macrophages (MΦs) and microglia accumulate in the brains of patients with human immunodeficiency virus (HIV) encephalitis (HIVE), a...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 406
SubjectTerms Adult
AIDS Dementia Complex - complications
AIDS Dementia Complex - immunology
AIDS Dementia Complex - pathology
Apoptosis
Brain
CD16 antigen
CD163 antigen
Cell activation
Cellular stress response
Coding
Cognition
Cognitive Dysfunction - immunology
Control methods
Dementia disorders
DNA microarrays
Encephalitis
Female
Gene expression
Gene Expression Profiling
Genes
HIV
HIV Infections - immunology
HIV Infections - pathology
Homeostasis
Human immunodeficiency virus
Humans
Immune response
Impairment
Macrophages
Male
Medical treatment
Microglia
Microglia - immunology
Middle Aged
Neuropathogenesis
Neurotrophic factors
Patients
Proteins
Ribonucleic acid
RNA
Viruses
Young Adult
Title Expression profiling suggests microglial impairment in human immunodeficiency virus neuropathogenesis
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fana.25160
https://www.ncbi.nlm.nih.gov/pubmed/29369399
https://www.proquest.com/docview/2006623721
https://www.proquest.com/docview/1991186656
Volume 83
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CDqGXpukr2yRFLT304o0tW7ZETktJCIHkUFLIoWD02mXpxlvW6xLy6zMjP0LaBkJuxpaRrXnok2b0DcAXobTVuuCRR7cYZY5nkTQmiXKVaOW8tEJTRPf8Ij_9kZ1diasNOOrPwrT8EMOGG1lG8Ndk4NrUh_ekobrSY5ycc1qvU64WAaLv99RRKg9MBBRmi0SSZj2rUMwPhzcfzkX_AMyHeDVMOCfb8LP_1DbP5Ne4WZuxvf2LxfGZ__IKXnZAlE1azdmBDV-9hq3zLtT-BvzxTZcjW7G2sDdOcqxuZhSQqtk1JfLNFqi9jA5azle0y8jmFQtF__DedVMtnSd-Cjrcyf7MV03NAnsmFUFezsjHzuu3cHlyfPntNOpqMkSWaGMiK51wUyfTbJpOlUU4qIUzOja51EIYUcSoFCqWLimcUVxwLYy0CS8MLxJt03ewWS0rvwsMoY_3SgmLgCFD-Zk4c7mkuOhUOvQKI_jaC6e0HV85lc1YlC3TMi9x1MowaiP4PDT93ZJ0_K_Rfi_hsrPTugyhJ57iMngEn4bHaGEUNtGVXzZ1SclhgRYwH8H7VjOGXjjVQ0SMhx8b5Pt49-XkYhIuPjy96R68QHwm2yTxfdhcrxp_gBhobT4GZb8DY_YDCQ
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEB6tFgm48GYpLGAQBy7pJk6cOBKXCu2qwLYHVKS9IMuvVhW7KWoahPj1zDiP1fKQELcodmTHnhl_9oy_AXglSm21Lnjk0SxGmeNZJI1JorxMdOm8tEKTR3c2z6efsvdn4mwP3vR3YVp-iOHAjTQj2GtScDqQPrpkDdWVHuPqnOOG_Rpl9A4bqo-X5FFlHrgIyNEWYWnW8wrF_Gj49Opq9BvEvIpYw5Jzchs-951tI02-jJudGdsfv_A4_u_f3IFbHRZlk1Z47sKer-7B9Vnnbb8P_vh7FyZbsTa3N65zrG5W5JOq2QXF8q3OUYAZ3bVcb-mgka0rFvL-4buLpto4TxQVdL-TfVtvm5oFAk3Kg7xZkZld1w9gcXK8eDuNurQMkSXmmMhKJ9zSyTRbpsvSIiLUwhkdm1xqIYwoYpSLMpYuKZwpueBaGGkTXhheJNqmD2G_2lT-ETBEP96XpbCIGbI0FybOXC7JNbqUDg3DCF73s6NsR1lOmTPOVUu2zBWOmgqjNoKXQ9WvLU_Hnyod9lOsOlWtVfA-8RR3wiN4MRSjkpHnRFd-09SK4sMCM2A-goNWNIZWOKVERJiHnQ0T_Pfm1WQ-CQ-P_73qc7gxXcxO1em7-YcncBPhmmxjxg9hf7dt_FOERDvzLEj-T4UTByQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Ja9wwFBYhhdBLm3SdJmnV0kMvntiyJUv0NDQZ0iVDKSnkUDDaPAxNPGE8LiG_vu_JS0gXKL0ZW0a29JZPek_fI-Q1V9pqnbPIg1mMMseySBqTREIlWjkvLdcY0T2ZieOv2YczfrZB3vZnYVp-iGHDDTUj2GtU8EtXHtyQhupKj8E5C1iv38lELFGkD7_ccEcpEagIMM4W8STNelqhmB0Mr952Rr8hzNuANXic6X3yrf_WNtHk-7hZm7G9_oXG8T9_Zpvc65AonbSis0M2fPWAbJ10sfaHxB9ddUmyFW0re4OXo3Uzx4hUTS8wk29-DuJL8aTlYoXbjHRR0VD1D-5dNNXSeSSowNOd9Mdi1dQ00GdiFeTlHI3son5ETqdHp--Oo64oQ2SRNyay0nFXOplmZVoqC3hQc2d0bITUnBuexyAVKpYuyZ1RjDPNjbQJyw3LE23Tx2SzWlb-KaGAfbxXiltADFkquIkzJyQGRkvpwCyMyJt-cgrbEZZj3YzzoqVaZgWMWhFGbUReDU0vW5aOPzXa62e46BS1LkLsiaWwDh6Rl8NjUDGMm-jKL5u6wOywwAsoRuRJKxlDLwwLIgLIg48N8_v37ovJbBIunv170xdk6_PhtPj0fvZxl9wFrCbbhPE9srleNX4f8NDaPA9y_xOMigXc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Expression+profiling+suggests+microglial+impairment+in+human+immunodeficiency+virus+neuropathogenesis&rft.jtitle=Annals+of+neurology&rft.au=Ginsberg%2C+Stephen+D&rft.au=Alldred%2C+Melissa+J&rft.au=Gunnam%2C+Satya+M&rft.au=Schiroli%2C+Consuelo&rft.date=2018-02-01&rft.eissn=1531-8249&rft.volume=83&rft.issue=2&rft.spage=406&rft_id=info:doi/10.1002%2Fana.25160&rft_id=info%3Apmid%2F29369399&rft.externalDocID=29369399
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0364-5134&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0364-5134&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0364-5134&client=summon